Zileuton, 5-lipoxygenase blocker, modulates acute inflammatory response in Nile tilapia. (PubMed, Dev Comp Immunol) - Mar 26, 2026 - "No clinical adverse effects were observed. To our knowledge, this is the first demonstration in fish that oral 5-LOX inhibition by zileuton mitigates acute inflammatory reaction, and underscores leukotriene pathway as a promising lever for improving fish health outcomes."
Journal • Inflammation • A2M • APOA1 • HP
|
|
Camila Carlino-Costa; Gabriel Conde; Leticia Franchin Rodrigues; Luiz Arthur Malta Pereira; Marco Antonio de Andrade Belo; Mayumi Fernanda Aracati; Patricia Bianca Clissa; Susana Luporini de Oliveira
|